Alivus Life Sciences Ltd
NSE: ALIVUS BSE: 543322
₹1044.95
(-0.49%)
Wed, 06 May 2026, 04:09 pm
Market Cap128.92B
PE Ratio23.63
Dividend0.48
Health Technology
Pharmaceuticals: Major
24.5KAlivus Life Sciences Financials
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.48M | 8.52B | 15.09B | 18.73B | 21.14B | 21.48B | 22.70B | 23.72B |
| Gross profit | 110.00K | 2.75B | 5.05B | 6.52B | 6.82B | 7.11B | 7.40B | 7.64B |
| Operating expenses (excl. COGS) | -240.00K | -718.47M | -864.70M | -971.28M | -1.05B | -1.13B | -1.20B | -1.43B |
| Selling/general/admin expenses, total | -240.00K | -700.75M | -842.37M | -949.32M | -1.02B | -1.09B | -1.18B | -1.39B |
| Research & development | — | -90.62M | -400.28M | -405.17M | -571.96M | -651.77M | -752.97M | -804.94M |
| Selling/general/admin expenses, other | -240.00K | -610.13M | -442.09M | -544.15M | -449.93M | -440.87M | -428.17M | -587.36M |
| Other operating expenses, total | 0 | -17.72M | -22.33M | -21.96M | -26.15M | -40.62M | -20.54M | -36.07M |
| Operating income | -130.00K | 2.03B | 4.18B | 5.54B | 5.77B | 5.97B | 6.20B | 6.21B |
| Non-operating income, total | 0 | 255.36M | 28.95M | -834.30M | -122.40M | 312.05M | 110.80M | 331.22M |
| Interest expense, net of interest capitalized | 0 | -6.05M | -335.15M | -875.47M | -279.62M | -5.47M | -15.46M | -24.14M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 0 | 261.41M | 364.10M | 41.17M | 157.22M | 317.52M | 126.26M | 279.21M |
| Non-operating interest income | 0 | 4.11M | 3.55M | 4.30M | 67.81M | 157.66M | 120.21M | 200.13M |
| Miscellaneous non-operating expense | 0 | 257.30M | 360.55M | 36.87M | 89.41M | 159.86M | 6.05M | 79.08M |
| Unusual income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 76.15M |
| Pretax income | -130.00K | 2.28B | 4.21B | 4.71B | 5.65B | 6.29B | 6.31B | 6.54B |
| Taxes | -4.21M | -327.05M | -1.08B | -1.19B | -1.46B | -1.62B | -1.60B | -1.69B |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -4.34M | 1.96B | 3.13B | 3.52B | 4.19B | 4.67B | 4.71B | 4.86B |
| Net income | -4.34M | 1.96B | 3.13B | 3.52B | 4.19B | 4.67B | 4.71B | 4.86B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -4.34M | 1.96B | 3.13B | 3.52B | 4.19B | 4.67B | 4.71B | 4.86B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - |
| EBITDA | -130.00K | 2.22B | 4.48B | 5.88B | 6.15B | 6.39B | 6.74B | 6.82B |
| EBIT | -130.00K | 2.03B | 4.18B | 5.54B | 5.77B | 5.97B | 6.20B | 6.21B |
| Total operating expenses | -2.61M | -6.49B | -10.91B | -13.19B | -15.37B | -15.51B | -16.50B | -17.51B |
| Prepaid expenses | — | — | 3.35M | 9.42M | 1.63M | 1.38M | 8.06M | 22.56M |
| Deferred income, current | — | 28.28M | 54.10M | 72.90M | 11.26M | 19.43M | 52.58M | 29.67M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 12.04M | 170.92M | 147.61M | 509.58M |
| Operating lease liabilities | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | 91.41M | 165.79M | 249.14M | 325.69M | 442.46M | 533.35M | 617.44M |
| Deferred income, non-current | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | -1.29B | -3.86B | -2.76B | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800